The Cancer Genome Atlas Research Network supports the fundamental role of oxygen-sensing genes (VHL) and chromatin remodeling genes (PBRM1, BAP1 and SETD2) in RCC tumorigenesis [9], highlighting their potential as prognostic biomarkers and/or future therapeutic targets. This evidence concerns the gene VHL and cancer.